Literature DB >> 24224870

Current concepts and future strategies in the management of intracranial germinoma.

Rolf-Dieter Kortmann1.   

Abstract

Radiation therapy is the backbone in the management of intracranial germinoma. In localized disease chemotherapy followed by whole brain irradiation is the present standard providing cure rates in excess of 90%. Craniospinal irradiation alone in metastatic disease provides equally excellent outcome. Chemotherapy is able to convert macroscopic to microscopic disease permitting a dose reduction to the tumor site and possibly the ventricular system and is investigated in prospective trials. Chemotherapy alone cannot replace radiotherapy as sole treatment. Whole-ventricular radiotherapy followed by a boost to tumor site without chemotherapy might be feasible. New treatment technologies such as intensity-modulated radiotherapy or proton therapy permit a dose reduction to non-target brain. Data on functional outcome are conflicting and based on small heterogeneous series only mandating prospective investigations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24224870     DOI: 10.1586/14737140.2014.856268

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  9 in total

1.  β-human chorionic gonadotropin-secreting intracranial germ-cell tumor associated with high testosterone in an adult man: A case report.

Authors:  Wen-Ping Yang; Hung-Yu Chien; Yi-Chun Lin
Journal:  Oncol Lett       Date:  2017-05-19       Impact factor: 2.967

2.  Treatment Outcome of a β-hCG Secreting Intracranial Germ Cell Tumor in an Adult Filipino Using Definitive Chemotherapy Followed by Radiotherapy: A Case Report.

Authors:  Florence Rochelle Gan; Maria Honolina Gomez; Julie Ann Tapispisan
Journal:  J ASEAN Fed Endocr Soc       Date:  2022-05-13

3.  Emergency irradiation of 3.4Gy/2f in pineal gland germinoma patients with symptomatic hydrocephalus.

Authors:  Bo Li; Youqi Li; Chunde Li; Yanwei Liu; Shuai Liu; Xiaoguang Qiu; Shiqi Luo
Journal:  Chin Neurosurg J       Date:  2019-06-03

4.  Management of dual intracranial germinoma by radiotherapy alone.

Authors:  Rakesh Gupta; Abhishek Songara
Journal:  J Pediatr Neurosci       Date:  2015 Jan-Mar

Review 5.  Re-irradiation of Recurrent Pineal Germ Cell Tumors with Radiosurgery: Report of Two Cases and Review of Literature.

Authors:  Kenneth Wong; Anthony B Opimo; Arthur J Olch; Sean All; Jonathan F Waxer; Desirae Clark; Justine Cheng; Alisha Chlebik; Anat Erdreich-Epstein; Mark D Krieger; Benita Tamrazi; Girish Dhall; Jonathan L Finlay; Eric L Chang
Journal:  Cureus       Date:  2016-04-25

6.  Emergency irradiation with 3.4 Gy/2f in sellar/suprasellar germinoma patients with rapid visual acuity decline.

Authors:  Bo Li; You-Qi Li; Chun-De Li; Yao Chen; Yan-Wei Liu; Shuai Liu; Xiao-Guang Qiu; Shi-Qi Luo
Journal:  Chin Med J (Engl)       Date:  2019-09-05       Impact factor: 2.628

7.  Radiographic Findings of an Intracranial Germinoma in a 42-Year-Old Male.

Authors:  Iger Ostreni; Menachem Gurevitz; Gerard Morvillo
Journal:  Cureus       Date:  2022-07-31

8.  Successful Treatment of Intracranial Germ Cell Tumor: Report of Two Unusual Cases and Literature Review.

Authors:  Ju Hyun Lee; In Sook Woo; Young Yun Cho; Won Jik Lee; Deok Jae Han; Chi Wha Han; Yun Hwa Jung
Journal:  Case Rep Oncol       Date:  2015-11-25

9.  EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults.

Authors:  Didier Frappaz; Girish Dhall; Matthew J Murray; Stuart Goldman; Cecile Faure Conter; Jeffrey Allen; Rolf Dieter Kortmann; Daphne Haas-Kogen; Giovanni Morana; Jonathan Finlay; James C Nicholson; Ute Bartels; Mark Souweidane; Stefan Schönberger; Alexandre Vasiljevic; Patricia Robertson; Assunta Albanese; Claire Alapetite; Thomas Czech; Chin C Lau; Patrick Wen; David Schiff; Dennis Shaw; Gabriele Calaminus; Eric Bouffet
Journal:  Neuro Oncol       Date:  2022-04-01       Impact factor: 13.029

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.